EC Number | Cloned (Comment) | Organism |
---|---|---|
1.14.14.155 | the enzyme is encoded on the large CAM plasmid of Pseudomonas putida, recombinant expression of N-terminally His6-tagged enzyme in Escherichia coli strain BL21(DE3) | Pseudomonas putida |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.14.14.155 | purified recombinant N-terminally His6-tagged enzyme, by Microbatch crystallization, mixing of 7 mg/ml protein in 20 mM FMN, 5 mM NADH and 5 mM (-)-camphor in a 1:1 ration, purified native enzyme, by vapour-diffusion technique, 10 mg/ml protein solution are mixed in equal volumes with 50 mM PIPES pH 6.5, 50% ammonium sulfate, room temperature, best from 100 mM HEPES pH 7.0, 20% PEG 3350 in the presence of 20 mM FMN, 5 mM NADH and 5 mM (-)-camphor, at 18°C, X-ray diffraction structure determination and analysis at 1.9-2.7 A resolution, the enzyme's crystal structure is solved by a combination of multiple anomalous dispersion from a bromine crystal soak and molecular replacement using a bacterial luciferase model | Pseudomonas putida |
1.14.14.155 | vapour-diffusion technique, three-dimensional structures of the native enzyme and the FMN complex of the overexpressed form of the oxygenating component of the type II Baeyer-Villiger 3,6-diketocamphane monooxygenase have been determined to 1.9 A resolution | Pseudomonas putida |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.14.155 | Pseudomonas putida | D7UER1 | - |
- |
1.14.14.155 | Pseudomonas putida NCIMB 10007 | D7UER1 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.14.14.155 | - |
Pseudomonas putida |
1.14.14.155 | recombinant N-terminally His6-tagged enzyme from Escherichia coli strain BL21(DE3) by nickel affinity chromatography and gel filtration | Pseudomonas putida |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.14.155 | culture condition:camphor-grown cell | - |
Pseudomonas putida | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.155 | additional information | mechanism of enantioselectivity for the hydroxyl-peroxide rearrangement taking place in the BVMO active site | Pseudomonas putida | ? | - |
? | |
1.14.14.155 | additional information | mechanism of enantioselectivity for the hydroxyl-peroxide rearrangement taking place in the BVMO active site | Pseudomonas putida NCIMB 10007 | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.14.14.155 | dimer | - |
Pseudomonas putida |
1.14.14.155 | dimer | three-dimensional structure analysis, overview | Pseudomonas putida |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.14.155 | 3,6-diketocamphane monooxygenase | - |
Pseudomonas putida |
1.14.14.155 | 3,6-DKMO | - |
Pseudomonas putida |
1.14.14.155 | type II Baeyer-Villiger 3,6-diketocamphane monooxygenase | - |
Pseudomonas putida |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.14.155 | FMN | dependent on, FMN cofactor modelling. Type II Baeyer-Villiger monooxygenases are attributed to the R group in relation to the re-face attachment of the hydroperoxide to the flavin coenzyme. The FMN cofactor binds in the cleft formed at the C-terminal side of the TIM barrel, with the phosphate group involved in hydrogen bonding at the edge of the cleft and the isoalloxazine ring located deep inside of the cleft | Pseudomonas putida | |
1.14.14.155 | FMN | FMN-dependent enzyme | Pseudomonas putida |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.14.14.155 | evolution | the orientation of the isoalloxazine ring of the FMN cofactor in the active site of the TIM-barrel fold enzyme differs significantly from that previously observed in enzymes of the bacterial luciferase-like superfamily. The Ala77 residue is in a cis conformation and forms a beta-bulge at the C-terminus of beta-strand 3, which is a feature observed in many proteins of this superfamily. Both the 2,5-DKMO and 3,6-DKMO oxygenating components have sequence similarity to bacterial luciferases and bear little similarity to type I Baeyer-Villiger monooxygenase, type I BVMOs | Pseudomonas putida |
1.14.14.155 | metabolism | the enzyme is involved in the camphor-degradation pathway, overview | Pseudomonas putida |
1.14.14.155 | additional information | the enzyme is a type II Baeyer-Villiger monooxygenase, enzyme structure modeling, active site structure, overview | Pseudomonas putida |